Physician profile
Caroline Hamel
NPI 1003881392
$894.06
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $98.62 · 2021: $148 · 2022: $131.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $368.95 | 2019-2022 | |
| Astellas Pharma US INC | $129.68 | 2019-2021 | |
| Hologic Sales and Service, LLC | $74.29 | 2019-2022 | |
| Pfizer INC. | $69.04 | 2019-2022 | |
| Amgen INC. | $58.93 | 2019 | |
| Amag Pharmaceuticals, INC. | $40.38 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.76 | 2019-2022 | |
| Ge Healthcare | $22.92 | 2021 | |
| Myovant Sciences INC. | $22.89 | 2022 | |
| Roche Diagnostics Corporation | $22.65 | 2019 | |
| Daiichi Sankyo INC. | $13.16 | 2020 | |
| Allergan, INC. | $12.25 | 2019 | |
| Hologic INC | $11.87 | 2022 | |
| Smith+Nephew, INC. | $11.29 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Hamel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.